The Impact of Insurance on Delivery of Huntington’s Care at an HDSA Center of Excellence
Objective: To determine the association between health insurance and Huntington’s Disease (HD) time to diagnosis, delays in access to specialty care, and HD specific clinical…Stimulation-Level Sweet-Spot and Connectivity Analysis of Pallidal DBS in Huntington’s Disease
Objective: To assess clinical outcomes and identify stimulation and structural connectivity patterns associated with motor improvement in Huntington’s Disease (HD) patients undergoing DBS. Background: DBS…Long-Term Safety and Efficacy of Valbenazine for Treating Huntington’s Disease Chorea
Objective: To present safety and efficacy results from a long-term study of once-daily valbenazine for chorea associated with Huntington’s disease (HD). Background: In a 12-week…Long-term results of pallidal deep brain stimulation in patients with Huntington’s disease
Objective: To analyze long-term results of pallidal (GPi) deep brain stimulation (DBS) in patients with Huntington's disease (HD). Background: In HD, DBS is suggested to…Analysis of Emergency Department Encounters and Hospital Admissions of People with Huntington’s Disease
Objective: Define characteristics of emergency department encounters and hospital admissions of people with Huntington’s disease and identify opportunities for intervention to reduce hospitalizations. Background: Huntington’s…Efficacy and Safety of Deutetrabenazine in Huntington’s Disease: a Systematic Review
Objective: To evaluate efficacy and safety of deutetrabenazine (DTB) in Huntington's Disease (HD) in order to guide evidence-based clinical decisions. Background: HD is a genetic…Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial
Objective: Evaluate whether 12 weeks of daily time-restricted eating (TRE) appears safe and feasible in persons with early-stage Huntington's disease (HD) and explore its effects…Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis
Objective: To assess the safety and efficacy of vesicular monoamine transporter 2 (VMAT2) inhibitors (deutetrabenazine, tetrabenazine, valbenazine) in managing chorea in Huntington’s Disease (HD). Background:…Adult-Onset Post-Pump Chorea: A Rare Manifestation Post-Cardiac Surgery in a Puerto Rican Patient
Objective: To report the first case of adult-onset post-pump chorea in Puerto Rico and raise awareness of our patient’s atypical age and onset of clinical…Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort
Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 12
- Next Page »